ASX ANNOUNCEMENT 31 July 2026 Quarterly Activities Report and Appendix 4C Bio-Gene Technology Limited ( ASX:BGT , “ Bio-Gene ” or “ the Company ”), an Australian agtech company developing the next generation of novel insecticides derived from nature, provides an update on...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX · · 10 pages · English
Release
Bio-Gene Technology Ltd. on 6ix
Earlier from Bio-Gene Technology
- Results of Placement
- Sumitomo & Nakashima to launch Qcide products in Japan
- Regulatory Development of Flavocide
- Appendix 4D and Half-Year Accounts 31 December 2025
- U.S. Department of Defense Grant Programs Advance
Later from Bio-Gene Technology
- Results of Meeting
- Application for quotation of securities - BGT
- Placement Completed and Cleansing Notice
- Change of Director's Interest Notice x 4
- Notification regarding unquoted securities - BGT
Follow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology